Literature DB >> 23206593

Optic nerve disease and axon pathophysiology.

Alireza Ghaffarieh1, Leonard A Levin.   

Abstract

Optic neuropathy is the most common cause of irreversible blindness worldwide. Although the most common optic neuropathy is glaucoma, there are also many other optic neuropathies, for example, those associated with multiple sclerosis, giant cell arteritis, ischemia, and many other diseases. In almost all cases, the pathogenesis involves injury to the retinal ganglion cell axon, with consequent somal and axonal degeneration. This chapter reviews the clinical and pathophysiological properties associated with three of the most common optic neuropathies, as well as recent findings in understanding axonal degeneration. It concludes with a status report on therapies for optic nerve disease, including axoprotection, an approach being studied that has the goal of maintaining axonal integrity and function after injury.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23206593     DOI: 10.1016/B978-0-12-398309-1.00002-0

Source DB:  PubMed          Journal:  Int Rev Neurobiol        ISSN: 0074-7742            Impact factor:   3.230


  18 in total

Review 1.  Neuronal endoplasmic reticulum stress in axon injury and neurodegeneration.

Authors:  Shaohua Li; Liu Yang; Michael E Selzer; Yang Hu
Journal:  Ann Neurol       Date:  2013-10-07       Impact factor: 10.422

2.  Minimally-invasive Technique for Injection into Rat Optic Nerve.

Authors:  Kateryna Raykova; Melina V Jones; Hwa Huang; Paul F Hoffman; Michael Levy
Journal:  J Vis Exp       Date:  2015-05-19       Impact factor: 1.355

3.  Up-regulation of SKIP relates to retinal ganglion cells apoptosis after optic nerve crush in vivo.

Authors:  Yu Wu; Fan Xu; Hui Huang; Lifei Chen; Meidan Wen; Li Jiang; Lu Lu; Li Li; Di Song; Siming Zeng; Li Li; Min Li
Journal:  J Mol Histol       Date:  2014-07-30       Impact factor: 2.611

4.  Zinc chelation and Klf9 knockdown cooperatively promote axon regeneration after optic nerve injury.

Authors:  Ephraim F Trakhtenberg; Yiqing Li; Qian Feng; Janice Tso; Paul A Rosenberg; Jeffrey L Goldberg; Larry I Benowitz
Journal:  Exp Neurol       Date:  2017-10-27       Impact factor: 5.330

5.  Neuroprotective Effect of Tauroursodeoxycholic Acid on N-Methyl-D-Aspartate-Induced Retinal Ganglion Cell Degeneration.

Authors:  Violeta Gómez-Vicente; Pedro Lax; Laura Fernández-Sánchez; Netxibeth Rondón; Gema Esquiva; Francisco Germain; Pedro de la Villa; Nicolás Cuenca
Journal:  PLoS One       Date:  2015-09-17       Impact factor: 3.240

6.  Alternating Current Stimulation for Vision Restoration after Optic Nerve Damage: A Randomized Clinical Trial.

Authors:  Carolin Gall; Sein Schmidt; Michael P Schittkowski; Andrea Antal; Géza Gergely Ambrus; Walter Paulus; Moritz Dannhauer; Romualda Michalik; Alf Mante; Michal Bola; Anke Lux; Siegfried Kropf; Stephan A Brandt; Bernhard A Sabel
Journal:  PLoS One       Date:  2016-06-29       Impact factor: 3.240

7.  Calpain-mediated cleavage of collapsin response mediator protein-2 drives acute axonal degeneration.

Authors:  Jian-Nan Zhang; Uwe Michel; Christof Lenz; Caroline C Friedel; Sarah Köster; Zara d'Hedouville; Lars Tönges; Henning Urlaub; Mathias Bähr; Paul Lingor; Jan C Koch
Journal:  Sci Rep       Date:  2016-11-15       Impact factor: 4.379

8.  Report on the National Eye Institute Audacious Goals Initiative: Replacement of Retinal Ganglion Cells from Endogenous Cell Sources.

Authors:  Monica L Vetter; Peter F Hitchcock
Journal:  Transl Vis Sci Technol       Date:  2017-03-15       Impact factor: 3.283

Review 9.  Bone Marrow-Derived Cells as a Therapeutic Approach to Optic Nerve Diseases.

Authors:  Louise A Mesentier-Louro; Camila Zaverucha-do-Valle; Paulo H Rosado-de-Castro; Almir J Silva-Junior; Pedro M Pimentel-Coelho; Rosalia Mendez-Otero; Marcelo F Santiago
Journal:  Stem Cells Int       Date:  2015-11-16       Impact factor: 5.443

10.  Activating Transcription Factor 3 (ATF3) Protects Retinal Ganglion Cells and Promotes Functional Preservation After Optic Nerve Crush.

Authors:  Christo Kole; Benedikt Brommer; Naoki Nakaya; Mohor Sengupta; Luis Bonet-Ponce; Tantai Zhao; Chen Wang; Wei Li; Zhigang He; Stanislav Tomarev
Journal:  Invest Ophthalmol Vis Sci       Date:  2020-02-07       Impact factor: 4.799

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.